- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
PPP1R13L antibody detects Protein phosphatase 1 regulatory subunit 13 like, a transcriptional regulator that interacts with p53, NF-kappaB, and protein phosphatase 1 (PP1) to control apoptosis and gene expression. The UniProt recommended name is Protein phosphatase 1 regulatory subunit 13 like (PPP1R13L). Also known as inhibitor of apoptosis-stimulating protein of p53 (iASPP), it acts as a negative regulator of p53-mediated transcription and apoptosis.
Functionally, PPP1R13L antibody identifies a 918-amino-acid nuclear and cytoplasmic protein that binds to the DNA-binding domain of p53, preventing the activation of pro-apoptotic genes such as BAX and PUMA. PPP1R13L also interacts with the RelA/p65 subunit of NF-kappaB, inhibiting its transcriptional activity and modulating inflammatory signaling. Through its association with PP1, it influences the phosphorylation state of nuclear proteins, linking phosphatase activity to transcriptional repression.
The PPP1R13L gene is located on chromosome 19q13.32 and is expressed in multiple tissues, including heart, liver, and brain, with elevated expression in dividing cells and tumors. Expression is induced by growth factors and oncogenic signals, reflecting its role in balancing survival and stress responses. PPP1R13L is part of the ASPP (apoptosis-stimulating proteins of p53) family, which fine-tunes p53 function depending on cellular context.
Pathologically, overexpression of PPP1R13L contributes to oncogenesis by suppressing p53-dependent apoptosis and enhancing cell survival under stress. High levels are found in breast, liver, and hematologic malignancies. Conversely, reduced expression sensitizes cells to apoptosis. Genetic variants have also been linked to cardiomyopathy and developmental abnormalities. Research using PPP1R13L antibody supports studies in apoptosis regulation, tumor biology, and transcriptional control.
PPP1R13L antibody can be validated for western blotting, immunofluorescence, and chromatin immunoprecipitation to detect transcriptional regulators. NSJ Bioreagents provides PPP1R13L antibody reagents optimized for studies in p53 signaling, phosphatase regulation, and apoptosis mechanisms.
Structurally, Protein phosphatase 1 regulatory subunit 13 like contains ankyrin repeats and an SH3 domain that mediate interactions with p53 and NF-kappaB, as well as PP1-binding motifs for phosphatase association. This modular structure allows PPP1R13L to serve as a multifunctional scaffold integrating transcriptional repression and survival signaling. This antibody supports investigation of PPP1R13L's role in cell fate determination, stress response, and tumor progression.
Optimal dilution of the PPP1R13L antibody should be determined by the researcher.
E.coli-derived human iASPP/PPP1R13L recombinant protein (Position: D94-Q753) was used as the immunogen for the PPP1R13L antibody.
After reconstitution, the PPP1R13L antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.